The degree of hemolysis is an essential indicator of the quality and integrity of blood products. With the HemoCue® Plasma/Low Hb System, you can easily and accurately estimate hemolysis directly at the point of care. Replace subjective visual judgment and have confidence in your answers.
In the laboratory, hemolysis is an important preanalytical factor that affects the accuracy and clinical utility of many test results. By assessing the degree of hemolysis before analysis, the sample can be accepted or rejected. The HemoCue® Plasma/Low Hb System makes it possible to easily and accurately estimate hemolysis without having to send the sample to a lab.
01
Results within 1 minute
02
Portability enables testing anywhere
03
Precise factory calibration against the ICSH reference method
04
Brief training with virtually no maintenance
05
Proprietary microcuvette technology with excellent lot-to-lot reproducibility
06
Blood-based liquid controls available
Customer stories
Sorry, no results were found.
System specifications
Principle
Modified azidemethemoglobin reaction; dual wavelengths (570 nm and 880 nm) for compensation of turbidity
Calibration
Factory calibrated against the ICSH reference method; needs no further calibration
Yes, there are control solutions available for the HemoCue® Plasma/Low Hb System. They are produced by EuroTrol B.V. and are available in 3 different levels.
The HemoCue® Hb 201+ System has a measuring range of 0.5-25.6 g/dL (5-256 g/L, 0.3-15.9 mmol/L), whereas the measuring for the HemoCue® Plasma/Low Hb System is 0.3-30.0 g/L (0.03-3.0 g/dL, 30.0-3000 mg/dL, 0.02-1.86 mmol/L).
You can use the following sample materials with the HemoCue® Plasma/Low Hb System: Plasma, serum, aqueous solutions or supernatant from erythrocyte suspensions.
To receive a digital version of the Instructions for Use for your system, fill in the form and we’ll reach out.
